Groww Logo
Home>US Stocks>AbbVie Inc

AbbVie Inc

Healthcare
$152.39
+ $0.67 (0.44%) 1D
1D
1W
1M
1Y
3Y
5Y

Performance

Today’s Low
$
    Today’s High
    $
    52W Low
    $
      52W High
      $
      Open PricePrev. CloseVolumeAvg. Volume
      $151.20$151.7213,0578,100,888

      Fundamentals

      Market Cap$268.10B
      P/B Ratio16.5
      P/E Ratio21.5
      Enterprise Value$335.48B
      Div. Yield3.72%
      Book Value9.19
      EPS(TTM)2.52
      ROENA
      Understand Fundamentals

      About the Company

      AbbVie is a relatively new biopharmaceutical company established in 2013; prior to that, it had been under Abbott Laboratories, sharing its legacy and rich history. Within just a few years AbbVie Inc. has established a stronghold over the scientific
      AbbVie is a relatively new biopharmaceutical company established in 2013; prior to that, it had been under Abbott Laboratories, sharing its legacy and rich history. Within just a few years AbbVie Inc. has established a stronghold over the scientific industry. Based in Chicago, Illinois, it markets its products in the entire United States, Germany, France, Italy, Canada, Japan, Spain, Brazil, the United Kingdom and the Netherlands. AbbVie focuses on providing patients with transformational medicines and therapies that would benefit and improve their lives. It aims to discover more than just a cure for the numerous severe diseases rampant across the world. Taking up new challenges is the principal vision of AbbVie and it has employed about 47,000 individuals across the globe in its search of difficult-to-cure illnesses. In 2020, it actively partook to find the vaccine to combat the Covid-19 pandemic. It donated an amount of $35 million to aid Covid-19 relief across the world. Its contribution to the development of its community and the global society, in general, has been recognised by esteemed directories like DiversityInc Top 50 Companies for Philanthropy, Dow Jones Sustainability World Index, The Civic 50. AbbVie Inc. entered the American stock market around the same time it was formed, with an initial stock price of $34.40. The company witnessed its highest-ever stock price on 26th January 2018, when it reached $123.21. It develops medications and therapies for some of the most difficult to deal with diseases and physical ailments. Few of its world-renowned products include its biological therapies, medical inhibitors, medicine for treating adults with leukaemia or lymphoma, medication for respiratory diseases, pancreatic enzyme therapy, and an array of treatments for rare and critical illnesses. Few of its most notable products include Humira, Skyrizi, Rinvoq, etc. The global sales of Ibrutinib, one of AbbVie’s most noted products, was estimated to be worth approximately $5 billion in 2020 – reaching 5 times more than the estimated amount in 2016, contributing to the company’s performance in terms of revenue generation.
      ...Read more
      OrganisationAbbVie Inc
      IndustryDrug Manufacturers—General
      HeadQuartersNorth Chicago, IL

      Company Financials

      *All values are in Million $
      No Graph Data To Display
      Quarterly
      Yearly
      See Details

      FAQs on AbbVie Inc

      Can I Buy AbbVie Inc Shares in India?

      Yes, AbbVie Inc shares can be bought in India by opening an international trading account with Groww.

      How to Buy AbbVie Inc Shares in India?

      One can easily invest in AbbVie Inc shares from India by: Direct Investment - Opening an international trading account with Groww which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy AbbVie Inc shares. Indirect Investment - Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of AbbVie Inc.

      What is the Share Price of AbbVie Inc?

      The share price of AbbVie Inc is in Dollars and if you are investing from India, you can always check the INR valuation before investing. The current AbbVie Inc share price is $152.39 as of 20 May ‘22

      What is the Market Cap of AbbVie Inc?

      The AbbVie Inc market cap is $268.10B as of 20 May ‘22

      What is the PE and PB ratio of AbbVie Inc?

      The PE and PB ratio of AbbVie Inc is 21.5 and 16.5 as of 20 May ‘22
      ⓒ 2016-2022 Groww. All rights reserved, Built with in India
      MOST POPULAR ON GROWWVERSION - 2.3.8
      STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
      MUTUAL FUNDS COMPANIES:  ICICI PRUDENTIAL |  HDFC |  NIPPON INDIA |  ADITYA BIRLA SUN LIFE |  SBI |  UTI |  FRANKLIN TEMPLETON |  KOTAK MAHINDRA |  IDFC |  DSP |  AXIS |  TATA |  L&T |  SUNDARAM |  PGIM |  INVESCO |  LIC |  JM FINANCIAL |  BARODA PIONEER |  CANARA ROBECO |  HSBC |  IDBI |  INDIABULLS |  MOTILAL OSWAL |  BNP PARIBAS |  MIRAE ASSET |  PRINCIPAL |  BOI AXA |  UNION KBC |  TAURUS |  EDELWEISS |  NAVI |  MAHINDRA |  QUANTUM |  PPFAS |  IIFL |  Quant |  SHRIRAM |  SAHARA |  ITI

      ABOUT GROWW